BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 16472623)

  • 1. Complementary stimulation of hepatobiliary transport and detoxification by rifampicin and ursodeoxycholic acid in humans.
    Duttala S; Tobi M; Dingell JD
    Gastroenterology; 2006 Feb; 130(2):619-20; author reply 620. PubMed ID: 16472623
    [No Abstract]   [Full Text] [Related]  

  • 2. Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans.
    Marschall HU; Wagner M; Zollner G; Fickert P; Diczfalusy U; Gumhold J; Silbert D; Fuchsbichler A; Benthin L; Grundström R; Gustafsson U; Sahlin S; Einarsson C; Trauner M
    Gastroenterology; 2005 Aug; 129(2):476-85. PubMed ID: 16083704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anicteric form of progressive familial intrahepatic cholestasis (Byler syndrome)].
    Masmoudi A; Hadj-Taieb I; Kammon T; Mseddi M; Boudaya S; Chaabouni M; Hachicha M; Turki H
    Ann Dermatol Venereol; 2008 Mar; 135(3):228-30. PubMed ID: 18374858
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurrent intrahepatic cholestasis of pregnancy: ursodeoxycholic acid should be the first line of treatment.
    Jain P
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):479-80. PubMed ID: 19104716
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intrahepatic cholestasis of pregnancy. New treatment].
    Ranek L; Ott P
    Ugeskr Laeger; 1999 Sep; 161(39):5411-2. PubMed ID: 10553352
    [No Abstract]   [Full Text] [Related]  

  • 6. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. A retrospective study of 19 cases.
    Berkane N; Cocheton JJ; Brehier D; Merviel P; Wolf C; Lefèvre G; Uzan S
    Acta Obstet Gynecol Scand; 2000 Nov; 79(11):941-6. PubMed ID: 11081677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intrahepatic cholestasis of pregnancy treated with ursodeoxycholic acid. Results from a two-year survey at Rigshospitalet, Skejby Hospital and Odense University Hospital].
    Jochumsen KM; Svane D; Bødker B; Skajaa K; Westergaard JG
    Ugeskr Laeger; 2003 Sep; 165(40):3825-8. PubMed ID: 14560505
    [No Abstract]   [Full Text] [Related]  

  • 8. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
    Stiefelhagen P
    MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
    [No Abstract]   [Full Text] [Related]  

  • 9. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
    Marschall HU
    Scand J Gastroenterol; 2016; 51(2):256. PubMed ID: 26315148
    [No Abstract]   [Full Text] [Related]  

  • 10. [Successful therapy of persistent androgen-induced cholestasis with ursodeoxycholic acid].
    Mörk H; al-Taie O; Klinge O; Scheurlen M
    Z Gastroenterol; 1997 Dec; 35(12):1087-91. PubMed ID: 9487641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of intrahepatic cholestasis in chronic diseases of the liver].
    Golovanova EV; Petrakov AV
    Ter Arkh; 2011; 83(2):33-9. PubMed ID: 21516847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis.
    Bécheur H; Dall'osto H; Chatellier G; Charton-Bain MC; Aubertin JM; Attar A; Bloch F; Petite JP
    Dig Dis Sci; 1997 Apr; 42(4):789-91. PubMed ID: 9125650
    [No Abstract]   [Full Text] [Related]  

  • 13. Ursodeoxycholic acid for intrahepatic cholestasis of pregnancy: good for the mother, not bad for the baby.
    Carey EJ; White P
    Evid Based Med; 2013 Dec; 18(6):e55. PubMed ID: 23635844
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy.
    Kondrackiene J; Beuers U; Kupcinskas L
    Gastroenterology; 2005 Sep; 129(3):894-901. PubMed ID: 16143129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ursodeoxycholic acid treatment in intrahepatic cholestasis of pregnancy. A case report].
    Lengyel G; Fehér R; Gardó S; Fehér J
    Orv Hetil; 2002 Dec; 143(52):2885-8. PubMed ID: 12638316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Use of Rifampin for Refractory Intrahepatic Cholestasis of Pregnancy.
    Liu J; Murray AM; Mankus EB; Ireland KE; Acosta OM; Ramsey PS
    Obstet Gynecol; 2018 Sep; 132(3):678-681. PubMed ID: 30095766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children.
    Lebensztejn DM
    Med Sci Monit; 2000; 6(3):632-6. PubMed ID: 11208384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. URSO in obstetric cholestasis: not a bear market.
    Elias E
    Gut; 1999 Sep; 45(3):331-2. PubMed ID: 10446097
    [No Abstract]   [Full Text] [Related]  

  • 19. Is ursodeoxycholic acid effective for intrahepatic cholestasis of pregnancy?
    Sepúlveda Marín S; Contreras Maragaño V; Vera C
    Medwave; 2016 Jan; 16 Suppl 1():e6361. PubMed ID: 26817509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic cholestasis of pregnancy: a case report.
    Konjeti R; Selsky N
    Conn Med; 2012 Mar; 76(3):163-4. PubMed ID: 22666977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.